The ISN and the International Diabetes Federation (IDF) have signed a Memorandum of Understanding, formalizing a long-term collaboration to strengthen global action on diabetes-related kidney disease. Diabetes is the leading cause of kidney disease, and together these conditions affect hundreds of millions of people worldwide. Recognizing their shared risk factors and growing global burden, the ISN and the IDF...
The “ISN Global Kidney Trials Insights: A Guide for Everyone,” inspired by the ISN-ACT Global Trials Focus summaries, translates complex trial findings into accessible information. This initiative empowers people living with kidney disease and their caregivers to better understand advancements in kidney care. Access all the simplified summaries here. The latest case study features the SMART...
The International Diabetes Federation Virtual Congress 2023, 4-7 December, will feature four days of high-level sessions on: Managing and treating diabetes complications, The impact of natural and human-made disasters on people with diabetes The long-term effects of COVID-19 Attractive registration rates are available, with discounts for students and healthcare professionals in low- and middle-income countries. Learn more at www.idf2023.org.
The consensus report identifies and highlights shared recommendations from the 2022 American Diabetes Association (ADA) Standards of Medical Care in Diabetes and the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Read the consensus report here. Consensus statements were drafted when recommendations from each organization aligned and...
